Thomas P. O'Neil Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas P. O'Neil.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas P. O'Neil. Thomas P. O'Neil is Chief Financial Officer in Protagonist Therapeutics, Inc ($PTGX) and Chief Financial Officer in Satsuma Pharmaceuticals, Inc. ($STSA).
Latest Insider Trading Transactions of Thomas P. O'Neil
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 03 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Option Exercise | M | 4.56 | 750 | 3,420 | 65,590 | |
Sep 03 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Sell | S | 22.19 | 750 | 16,645 | 0 | 750 to 0 (-100.00 %) |
Sep 03 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Buy | M | 4.56 | 750 | 3,420 | 750 | 0 to 750 |
Aug 07 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Option Exercise | M | 4.56 | 1,000 | 4,560 | 66,340 | |
Aug 07 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Sell | S | 25.00 | 1,000 | 25,000 | 0 | 1,000 to 0 (-100.00 %) |
Aug 07 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Buy | M | 4.56 | 1,000 | 4,560 | 1,000 | 0 to 1,000 |
Jun 24 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Option Exercise | M | 1.04 | 2,115 | 2,200 | 74,480 | |
Jun 24 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Sell | S | 35.23 | 2,115 | 74,512 | 0 | 2.1 K to 0 (-100.00 %) |
Jun 24 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Buy | M | 1.04 | 2,115 | 2,200 | 2,115 | 0 to 2.1 K |
Jun 02 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Option Exercise | M | 4.56 | 1,000 | 4,560 | 68,340 | |
Jun 02 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Sell | S | 25.32 | 1,000 | 25,324 | 0 | 1,000 to 0 (-100.00 %) |
Jun 02 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Buy | M | 4.56 | 1,000 | 4,560 | 1,000 | 0 to 1,000 |
May 21 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Option Exercise | M | 4.56 | 2,000 | 9,120 | 69,340 | |
May 21 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Sell | S | 25.00 | 2,000 | 50,000 | 0 | 2 K to 0 (-100.00 %) |
May 21 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Buy | M | 4.56 | 2,000 | 9,120 | 2,000 | 0 to 2 K |
Mar 12 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Option Exercise | M | 4.56 | 1,000 | 4,560 | 71,340 | |
Mar 12 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Sell | S | 27.68 | 1,000 | 27,678 | 0 | 1,000 to 0 (-100.00 %) |
Mar 12 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Buy | M | 4.56 | 1,000 | 4,560 | 1,000 | 0 to 1,000 |
Mar 06 2020 | STSA | Satsuma Pharmaceut ... | O'Neil Thomas P. | Chief Financial Off ... | Option Exercise | A | 29.00 | 60,000 | 1,740,000 | 60,000 | |
Aug 17 2018 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Option Exercise | A | 8.58 | 14,050 | 120,549 | 14,050 | |
Aug 17 2018 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Grant | A | 0.00 | 21,100 | 0 | 30,560 | 9.5 K to 30.6 K (+223.04 %) |
Mar 02 2018 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Option Exercise | A | 16.95 | 34,000 | 576,300 | 34,000 | |
Mar 02 2018 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Grant | A | 0.00 | 6,000 | 0 | 8,858 | 2.9 K to 8.9 K (+209.94 %) |
Dec 20 2017 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Option Exercise | M | 4.21 | 4,000 | 16,840 | 28,998 | |
Dec 20 2017 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Option Exercise | M | 1.16 | 4,000 | 4,640 | 57,666 | |
Dec 20 2017 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Sell | S | 20.00 | 8,000 | 160,000 | 0 | 8 K to 0 (-100.00 %) |
Dec 20 2017 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Buy | M | 4.21 | 4,000 | 16,840 | 8,000 | 4 K to 8 K (+100.00 %) |
Dec 20 2017 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Buy | M | 1.16 | 4,000 | 4,640 | 4,000 | 0 to 4 K |
Oct 13 2016 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Option Exercise | A | 21.58 | 45,000 | 971,100 | 45,000 |
Page: 1